Malcolm Hoenlein
CIK 1294517 · last filed 2026-01-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.55M
Companies
7
Total Filings
37
Lifetime Open-Market Net
$340.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FBIOP | Director | 115,747 | $20.71 | $2.40M | $300.0K | 10 | 2026-01-05 |
| DarioHealth Corp. (DRIOW) Delisted | Director | 78,033 | — | — | $0 | 8 | 2018-06-08 |
| FBIO | Director | 55,000 | $2.77 | $152.3K | $0 | 3 | 2017-07-21 |
| DarioHealth Corp. (DRIO.W) Delisted | Director | 19,168 | — | — | $0 | 1 | 2016-08-17 |
| Fortress Biotech, Inc. (CNDO) Delisted | Director | 55,000 | — | — | $40.2K | 2 | 2014-11-10 |
| KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Director | 110,000 | — | — | $0 | 3 | 2008-11-18 |
| TG THERAPEUTICS, INC. (MHA) Delisted | Director | 4,861 | — | — | $0 | 1 | 2007-04-27 |
Recent Filings · Page 4 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-03-10 | — | Grant (A) | — | $0 | |
| 2009-08-21 | — | Grant (A) | +250,000 | $0 | |
| 2008-11-18 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +110,000 | $0 | EDGAR |
| 2008-06-20 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-03-28 | — | Grant (A) | — | $0 | |
| 2007-06-22 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-04-27 | TG THERAPEUTICS, INC. (MHA) Delisted | Grant (A) | +4,861 | $0 | EDGAR |
Showing 31–37 of 37
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.